Leukemia & Lymphoma Society (LLS): Myelodysplastic Syndromes (MDS)

Not Funded
About
The Leukemia & Lymphoma Society (LLS) offers the Myelodysplastic Syndromes (MDS) program to assist patients with their treatment costs for drugs such as Gleevec, Jakafi, Neupogen, and many others. This program benefits U.S. citizens or permanent residents diagnosed with blood cancers who meet income guidelines, providing coverage for chemotherapy or prescription medications related to their diagnosis. Patients can quickly begin utilizing the award upon approval, easing financial burdens during treatment.
Insurance requirements: Commercially insured, Medicare / Medicaid, Underinsured
Enrollment Forms
Enrollment Form
Benefits
$3500 annual maximum benefit
Program Requirements
Valid only for residents in the US and Puerto Rico
Enrollment Required: Yes
Coverage Required: No
Needs Based: Yes
Activation Required: No
Program Details
Please note that specific drug coverage is not indicated on program website; drug coverage must be verified by calling program at 8775572672
LLS covers all products prescribed by the patient’s physician to treat their primary cancer diagnosis classified as a chemotherapy or prescription related to their covered diagnosis
All products must be covered by the patient’s primary insurance provider
Patients, caregivers, pharmacies, and healthcare providers can apply by phone or online
Patients must have a valid email address to register & providers will need their NPI
Once registered, patients will receive an email directing to a website to create a password; application form can then be entered
To apply, patient will need to supply SSN or Alien ID, DOB, diagnosis, insurance details (group, policy, and ID numbers), Medicare/Medicaid info, physician, and pharmacy details
Once the application is submitted, the approval/denial or pending status will be provided immediately
If the application is approved, the patient can begin using the award right away with the virtual pharmacy copay card that will be attached to the award message
LLS will fax a physician's form to the treating HCP; the completed form must be received within 30 days of the approval, or the award will be closed, and no further claims may be submitted
Any required documentation can be uploaded to the portal, as well as claim submissions and payment requests
Other Programs

Assistance Fund: Biliary Tract Cancer

Commercially Insured
Medicare / Medicaid

Assistance Fund: Biliary Tract Cancer: Waitlist

Commercially Insured
Medicare / Medicaid
Other Tools for Pemazyre